{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T11:35:17Z","timestamp":1767353717162,"version":"3.48.0"},"reference-count":18,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background:\u00a0Klebsiella species are a leading cause of Gram-negative bacteremia associated with nosocomial infections. They exhibit higher antimicrobial resistance compared to other Enterobacterales, emphasizing their role as a \u201csentinel organism\u201d. While the impact of inappropriate empiric therapy has been studied, data specific to Klebsiella bacteremia are limited due to small sample sizes. This study aims to provide high-resolution data on Klebsiella bacteremia and assess the impact of appropriate empirical therapy on clinical outcomes. Methods: We conducted a retrospective study of patients with Klebsiella bacteremia hospitalized at Beilinson Hospital between 2012 and 2022. Patients were categorized into two groups based on the appropriateness of empiric therapy. The primary outcome was 30-day all-cause mortality; subgroup analyses evaluated mortality in ESBL bacteremia treated with either carbapenems or piperacillin-tazobactam, and carbapenems versus aminoglycosides. Propensity score weighting and inverse probability treatment-weighted models were used to adjust for confounding. Results: Among 1132 patients, 79% received appropriate empirical therapy. This therapy was associated with reduced 30-day mortality (OR = 0.59, 95% CI: 0.46\u20130.76) and a shorter hospital stay (median 7 vs. 11 days, p &lt; 0.001). Other significant risk factors for mortality included a higher Charlson comorbidity score (OR = 1.06), assistance with ADL (OR = 2.16), prior hospitalization (OR = 1.31), and a higher SOFA score (OR = 1.32). No significant mortality differences were observed in ESBL subgroups treated with carbapenems versus piperacillin-tazobactam (p = 0.2) or carbapenems versus aminoglycosides (p = 0.9). Conclusions: Early appropriate empirical therapy significantly reduces 30-day mortality in Klebsiella bacteremia. These findings highlight the importance of timely, appropriate empirical therapy and suggest choosing less broad-spectrum therapy. However, the lack of molecular data on resistance mechanisms limits the ability to assess strain-specific outcomes and may affect generalizability. Despite this, the study offers valuable insights for optimizing empirical therapy and advancing antimicrobial stewardship in the era of rising resistance.<\/jats:p>","DOI":"10.3390\/jcm15010337","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T11:11:46Z","timestamp":1767352306000},"page":"337","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Impact of Early Empirical Antibiotic Therapy on the Mortality of Bacteremia Patients with Klebsiella Infection: A Retrospective Cohort Study"],"prefix":"10.3390","volume":"15","author":[{"given":"Alaa","family":"Atamna","sequence":"first","affiliation":[{"name":"Infectious Diseases Unit, Rabin Medical Center, Beilinson Hospital, 39 Jabotinsky St., Petah-Tikva 49100, Israel"},{"name":"Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 6139001, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya","family":"Babich","sequence":"additional","affiliation":[{"name":"Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 6139001, Israel"},{"name":"Biostatistics Unit, Research Authority, Rabin Medical Center, Beilinson Hospital, Petah-Tikva 49100, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amar","family":"Nahhas","sequence":"additional","affiliation":[{"name":"Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 6139001, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anan","family":"Zreik","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Rabin Medical Center, Beilinson Hospital, 39 Jabotinsky St., Petah-Tikva 49100, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6020-4383","authenticated-orcid":false,"given":"Abed","family":"Agbaria","sequence":"additional","affiliation":[{"name":"Beit Rivka Geriatric Medical Center, Petah-Tikva 49100, Israel"},{"name":"Rabin Medical Center, Beilinson Hospital, Petah-Tikva 49100, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahd","family":"Dahamsheh","sequence":"additional","affiliation":[{"name":"Rabin Medical Center, Beilinson Hospital, Petah-Tikva 49100, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mouhammad","family":"Haj Yahya","sequence":"additional","affiliation":[{"name":"Rabin Medical Center, Beilinson Hospital, Petah-Tikva 49100, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haim","family":"Ben-Zvi","sequence":"additional","affiliation":[{"name":"Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 6139001, Israel"},{"name":"Clinical Microbiology Laboratory, Rabin Medical Center, Beilinson Hospital, Petah-Tikva 49100, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihad","family":"Bishara","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Rabin Medical Center, Beilinson Hospital, 39 Jabotinsky St., Petah-Tikva 49100, Israel"},{"name":"Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 6139001, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.cmi.2015.10.034","article-title":"Gram-negative bacteraemia; a multi-centre prospective evaluation of empirical antibiotic therapy and outcome in English acute hospitals","volume":"22","author":"Fitzpatrick","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e7924","DOI":"10.1097\/MD.0000000000007924","article-title":"Risk factors of mortality in bloodstream infections caused by Klebsiella pneumonia: A single-center retrospective study in China","volume":"96","author":"Li","year":"2017","journal-title":"Medicine"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.amjmed.2009.03.034","article-title":"Incidence, risk factors, and outcomes of Klebsiella pneumoniae bacteremia","volume":"122","author":"Meatherall","year":"2009","journal-title":"Am. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Tamma, P.D., Heil, E.L., Justo, J.A., Mathers, A.J., Satlin, M.J., and Bonomo, R.A. (2024). Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections. Clin. Infect. Dis., ciae403.","DOI":"10.1093\/cid\/ciae403"},{"key":"ref_5","unstructured":"(2023). Antimicrobial Resistance Surveillance in Europe 2023\u20132021 Data, European Centre for Disease Prevention and Control and World Health Organization."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/AAC.03935-14","article-title":"Stratification of the impact of inappropriate empirical antimicrobial therapy for Gram-negative bloodstream infections by predicted prognosis","volume":"59","author":"Cain","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1001\/jama.2018.12163","article-title":"Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial","volume":"320","author":"Harris","year":"2018","journal-title":"JAMA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Lodise, T.P., Zhao, Q., Fahrbach, K., Gillard, P.J., and Martin, A. (2018). A systematic review of the association between delayed appropriate therapy and mortality among patients hospitalized with infections due to Klebsiella pneumoniae or Escherichia coli: How long is too long?. BMC Infect. Dis., 18.","DOI":"10.1186\/s12879-018-3524-8"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3109\/00365549709035903","article-title":"Antibiotic therapy and outcome of monomicrobial Gram-negative bacteraemia: A 3-year population-based study","volume":"29","author":"Pedersen","year":"1997","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2796.1998.00379.x","article-title":"The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection","volume":"244","author":"Leibovici","year":"1998","journal-title":"J. Intern. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1128\/AAC.00466-06","article-title":"Impact of inactive empiric antimicrobial therapy on inpatient mortality and length of stay","volume":"50","author":"Scarsi","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1128\/AAC.00462-11","article-title":"Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: A propensity score-based analysis","volume":"56","author":"Retamar","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e2249353","DOI":"10.1001\/jamanetworkopen.2022.49353","article-title":"Association of Appropriate Empirical Antimicrobial Therapy With In-Hospital Mortality in Patients With Bloodstream Infections in the US","volume":"6","author":"Ohnuma","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Wu, X., Shi, Q., Shen, S., Huang, C., and Wu, H. (2021). Clinical and Bacterial Characteristics of Klebsiella pneumoniae Affecting 30-Day Mortality in Patients With Bloodstream Infection. Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.688989"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1017\/ice.2017.197","article-title":"Carbapenem Resistance, Initial Antibiotic Therapy, and Mortality in Klebsiella pneumoniae Bacteremia: A Systematic Review and Meta-Analysis","volume":"38","author":"Kohler","year":"2017","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s40121-021-00408-8","article-title":"The Impact of Carbapenem Resistance on Mortality in Patients With Klebsiella Pneumoniae Bloodstream Infection: An Individual Patient Data Meta-Analysis of 1952 Patients","volume":"10","author":"Maraolo","year":"2021","journal-title":"Infect. Dis. Ther."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/1\/337\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T11:32:08Z","timestamp":1767353528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/1\/337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["jcm15010337"],"URL":"https:\/\/doi.org\/10.3390\/jcm15010337","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]}}}